Sensotrend Pitch Deck Teardown: Solving the Diabetes Data

An analysis of the Sensotrend demo day deck, focusing on their approach to aggregating diabetes device data and their long-term clinical roadmap.

Sensotrend’s pitch deck, presented at a Startup Sauna Demo Day, addresses the fragmented landscape of diabetes management. The deck highlights the 'Old Way' of manual logging (Slide 2) and proposes a unified dashboard that aggregates data from insulin pumps, glucose monitors, and activity trackers (Slide 3). The team leverages significant domain expertise, including a founder with 15 years of personal experience with Type 1 diabetes (Slide 5). While the deck successfully establishes the market scale using IDF Diabetes Atlas 2013 data (Slide 7) and projects a growth path toward medical device…

Key takeaways

Sensotrend Pitch Deck Analysis

The Sensotrend deck, presented at a Startup Sauna Demo Day, is a classic example of a vision-led healthcare pitch. It focuses heavily on the 'why' and the 'who,' leveraging the personal story of the founders to validate the 'what.' While the deck is visually clean and follows a logical progression, it leaves several critical business questions unanswered, which is common for early-stage demo day presentations intended to spark initial interest rather than close a round on the spot.

Slide 1: Title Slide

The deck opens with the Sensotrend logo and the tagline "...making sense of diabetes trends." The branding is minimalist, using a blue circle (a common symbol in diabetes awareness) to replace the 'o' in Sensotrend. This immediately identifies the niche and the value proposition: data interpretation.

Slide 2: The Problem - The Old Way

Slide 2 uses a full-bleed background image of a spiral notebook and a pen with the text "THE OLD WAY: MANUAL ENTRY." This is a powerful, albeit simple, way to illustrate the friction in current diabetes management. It highlights that the status quo is analog, prone to error, and burdensome for the patient. By framing the problem this way, the solution becomes an obvious necessity rather than a luxury.

Slide 3: The Solution - Data Aggregation

This slide visualizes the product's architecture. It shows four categories of external inputs: a smartphone, a Jawbone activity tracker, an Accu-Chek glucose meter, and a Medtronic/CareLink insulin pump system. Arrows point from these devices toward the Sensotrend logo, which then feeds into a multi-device dashboard (laptop, tablet, and smartphone). This slide clearly defines Sensotrend as a software-only aggregator that harmonizes data from a fragmented hardware market.

Slide 4: Roadmap and Milestones

2014: Launch in Finland. · 2015: International Launch. · 2016: Clinical trials. · 2017: Medical Device Certification. · 2018: Data analytics.

Analysis: The inclusion of "Medical Device Certification" in 2017 is a critical detail. It suggests the company understands the regulatory hurdles of MedTech. However, the five-year span is quite long for a startup deck, and investors might question the capital requirements to sustain the company until the 2018 analytics phase.

Slide 5: The Team and Advisors

This is arguably the strongest slide in the deck. It lists three core team members: Mikael (Type 1 diabetic for 15 years, software pro for 16 years), Assi (Healthcare PR, marketing, and sales), and Jere (Software pro and mobile app startup experience). The combination of personal lived experience and professional tenure is highly persuasive. Below the core team, they list three Medical Doctors (Pirjo Ilanne-Parikka, Jorma Lahtela, and Päivi Hannula) associated with major Finnish medical institutions. This provides the necessary clinical credibility for a health-focused startup.

Slide 6: Contact Information

A mid-deck contact slide featuring Mikael Rinnetmäki’s email, phone number, and Twitter handle. While usually reserved for the end, placing it here suggests this might have been the final slide of a shorter version of the pitch, or a transition point in the presentation.

Slide 7: Global Market Opportunity

Citing the "IDF: Diabetes Atlas 2013," this slide uses a map to show global healthcare spending related to diabetes. The figures are massive: $263B in North America, $147B in Europe, and $88B in the Western Pacific. While these numbers represent the total cost of the disease rather than the addressable market for a software app, they serve to illustrate the scale of the problem Sensotrend is tackling.

Slide 8: Market Growth and Penetration

This slide provides more granular data from "research2guidance." It shows a bar chart of the "Addressable market" and "Diabetes app users," with a red line indicating "Penetration." The slide notes a jump from $4.1 M in 2013 to $465 M in 2018. This 100x growth projection in the specific niche of diabetes apps is much more relevant to an investor than the total healthcare spend shown on the previous slide.

What Works in the Sensotrend Deck

1. Founder-Market Fit: The team slide (Slide 5) is excellent. In health tech, having a founder who is also a patient (Mikael) provides a level of empathy and insight that cannot be manufactured. Combining that with 16 years of software experience mitigates the risk of technical execution.

2. Clear Problem/Solution Gap: The transition from Slide 2 (the notebook) to Slide 3 (the automated dashboard) is a textbook example of how to present a digital transformation play. It makes the value proposition—saving time and increasing accuracy—immediately apparent.

3. Regulatory Awareness: Many health startups fail to account for the time and cost of certification. By explicitly listing "Medical Device Certification" on their roadmap (Slide 4), Sensotrend signals to investors that they are not just building a "wellness app," but a serious clinical tool.

What is Missing from the Sensotrend Deck

1. The Business Model: There is no mention of how Sensotrend makes money. Is it a subscription for patients? A licensing fee for clinics? A data play for pharmaceutical companies? Without this, it is impossible to evaluate the financial viability of the company.

2. Competitive Landscape: The diabetes tech space is crowded. Companies like Glooko, Dexcom, and even Apple/Google were making moves in health data during this period. Sensotrend does not explain why their dashboard is superior to the native apps provided by the hardware manufacturers (like the CareLink system shown on Slide 3).

3. The Ask: A pitch deck is a fundraising tool. This deck fails to state how much money they are looking for, what the terms are, or what specific milestones the new capital will unlock. Even in a demo day setting, a "we are raising X amount" bullet point is standard.

4. Unit Economics: While the market growth is shown (Slide 8), there is no data on Customer Acquisition Cost (CAC) or Lifetime Value (LTV). For a mobile-first application, these metrics are vital for understanding if the business can scale profitably.

Founder's Guide: What to Copy

Use Visual Analogies for the Problem: The use of the notebook in Slide 2 is a great way to evoke the "pain" of the current process without using a wall of text. Founders should look for a single image that represents the inefficiency they are solving.

Highlight Clinical Advisors: If you are in a regulated space, your advisors are as important as your founders. Sensotrend’s inclusion of MDs from the Finnish Diabetes Association (Slide 5) adds immediate weight to their claims.

Cite Reputable Sources: Using the IDF Diabetes Atlas and research2guidance (Slides 7 and 8) gives the market data an air of objectivity. Always use third-party data to validate the size of your opportunity rather than making internal guesses.

Final Thoughts

Sensotrend’s deck is a strong "vision" pitch. It identifies a massive global problem, presents a logical software solution, and introduces a team that is uniquely qualified to build it. However, as a "fundraising" pitch, it is incomplete. To move to a term sheet, the founders would need to supplement these slides with a deep dive into their revenue model, their competitive moat, and their specific capital requirements. The roadmap is ambitious, but the lack of financial data makes it difficult to assess the risk-to-reward ratio for a potential investor.

Frequently asked questions

What is the core product Sensotrend is building?
Sensotrend is building a cross-platform data aggregation dashboard for diabetes management. As shown on Slide 3, the software pulls data from various third-party hardware devices—including activity trackers like Jawbone, glucose meters like Accu-Chek, and insulin pumps—and presents them in a unified interface accessible via web, tablet, and mobile devices.
How does the team demonstrate founder-market fit?
The team slide (Slide 5) highlights that the lead founder, Mikael, has lived with Type 1 diabetes for 15 years and has 16 years of software experience. This combination of personal patient experience and technical proficiency is a strong signal to investors that the product is built to solve real-world user pain points.
What are the key milestones on the Sensotrend roadmap?
According to Slide 4, the company planned a launch in Finland in late 2014, followed by an international launch in 2015. The roadmap includes clinical trials in 2016, achieving Medical Device Certification in 2017, and moving into advanced data analytics by 2018.
What market data does Sensotrend use to justify the opportunity?
Sensotrend uses two primary sources: the IDF Diabetes Atlas 2013 for global healthcare expenditure (Slide 7) and research2guidance for the growth of the diabetes app market (Slide 8). The latter predicts the market will grow from $4.1 million to $465 million over a five-year period.
What is missing from this pitch deck?
The deck is notably missing a business model slide explaining how they charge for the service (B2B vs. B2C). It also lacks a 'The Ask' slide, meaning there is no information on how much capital they are raising or how they intend to use the funds. Finally, there is no mention of existing competitors or their specific competitive advantage.
Cover slide of the Sensotrend pitch deck — Early Stage (Demo Day) 2013
Sensotrend pitch deck, slide 1 (2013)

Sensotrend pitch deck: the facts

Company
Sensotrend
Year
2013/2014 (…
Stage
Early Stage (Demo Day)
Slides
15
Sector
HealthTech / Diabetes Management
Deck type
Demo Day Pitch
Outcome
Not stated
Headquarters
Finland

Sensotrend pitch deck PDF

The full Sensotrend deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

Related fundraising guides (24)

Decks from the same year (1)

Decks from the same region (1)

Browse companies alphabetically (1)

More pitch deck teardowns (16)

Recently published pitch deck teardowns (12)

Fundraising library · Pitch deck examples · Investor directory · Founder database